0001437749-18-012234.txt : 20180621 0001437749-18-012234.hdr.sgml : 20180621 20180621163048 ACCESSION NUMBER: 0001437749-18-012234 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180619 FILED AS OF DATE: 20180621 DATE AS OF CHANGE: 20180621 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Klausner Mark R. CENTRAL INDEX KEY: 0001732629 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36200 FILM NUMBER: 18912113 MAIL ADDRESS: STREET 1: C/O OXFORD IMMUNOTEC GLOBAL STREET 2: 94C INNOVATION DRIVE, MILTON PARK CITY: ABINGDON, OXFORDSHIRE STATE: X0 ZIP: OX14 4RZ ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Oxford Immunotec Global PLC CENTRAL INDEX KEY: 0001586049 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 000000000 STATE OF INCORPORATION: X0 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ BUSINESS PHONE: 44 01235 442780 MAIL ADDRESS: STREET 1: 94C INNOVATION DRIVE STREET 2: MILTON PARK CITY: ABINGDON STATE: X0 ZIP: OX14 4RZ 4 1 rdgdoc.xml FORM 4 X0306 4 2018-06-19 0001586049 Oxford Immunotec Global PLC OXFD 0001732629 Klausner Mark R. C/O OXFORD IMMUNOTEC GLOBAL 94C INNOVATION DRIVE ABINGDON, OXFORDSHIRE X0 OX14 4RZ UNITED KINGDOM 1 SHARE OPTION (RIGHT TO BUY) 14.49 2018-06-19 4 A 0 7457 0 A 2028-06-19 ORDINARY SHARES 7457 7457 D The option will vest and become exercisable as to 100% of the underlying shares on the date of the first annual meeting of the issuer's shareholders held after the date of grant. /s/ Anthony P. Ferman, as Attorney-in-Fact for Mark Klausner 2018-06-21